Objective: To evaluate the preferences of an ethnically diverse national sample of older Americans regarding length of life versus health quality. Method: A time trade-off task administered as part of the 2002 wave of the Health and Retirement Study. Results: Respondents equated 6.86 (SD = 3.46) years of perfect health with 10 years of life in imperfect health. Women and those who ranked their health less favorably were more likely to give up years of life for perfect health. Relative to Whites, Blacks were more willing to live longer in imperfect health. Those of lower levels of education were more likely to prefer 10 years of life in imperfect health. Discussion: There is wide variability in responses to the time trade-off task that is partially associated with self-rated health, gender, ethnicity, and education.
Arnesen, T.M., & Norheim, O.F. ( 2003). Quantifying quality of life for economic analysis: time out for time trade off. Medical Humanities, 29(2), 81-86.
2.
Arnesen, T., & Trommald, M. ( 2005). Are QALYs based on time trade-off comparable?-A systematic review of TTO methodologies. Health Economics, 14, 39-53.
3.
Barnato, A.E., Anthony, D.L., Skinner, J., Gallagher, P.M., & Fisher, E.S. ( 2009). Racial and ethnic differences in preferences for end-of-life treatment. Journal of General Internal Medicine, 24, 695-701.
4.
Brandt, J., Spencer, M., & Folstein, M. ( 1988). The telephone interview for cognitive status. Neuropsychiatry , Neuropsychology, & Behavioral Neurology, 1(2), 111-117.
5.
Bryce, C.L., Angus, D.C., Switala, J., Roberts, M.S., & Tsevat, J. ( 2004). Health status versus utilities of patients with end-stage liver disease. Quality of Life Research, 13, 773-782.
6.
Bult, J.R., Hunink, M.G.M., Tsevat, J., & Weinstein, M.C. (1998). Heterogeneity in the relationship between the time tradeoff and short form-36 for HIV-infected and primary care patients. Medical Care, 36, 523-532.
7.
Burstrom, K., Johannesson, M., & Diderichsen, F. (2006). A comparison of individual and social time trade-off values for health states in the general population . Health Policy, 76, 359-370.
8.
Craig, B.M., Busschbach, J.J.V., & Salomon, J.A. ( 2009). Modeling ranking, time trade-off, and Visual Analog Scale values for EQ-5D health states: A review and comparison of methods. Medical Care, 47, 634-641.
9.
de Vries, S.O., Kuipers, W.D., & Hunink, M.G. ( 1998). Intermittent claudication: Symptom severity versus health values. Journal of Vascular Surgery, 27, 422-430.
10.
Dolan, P., Gudex, C., Kind, P., & Williams, A. ( 1996). The time trade-off method: Results from a general population study. Health Economics, 5, 141-154.
11.
Folstein, M.F., Folstein, S.E., McHugh, P.R. ( 1975). "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatry Research, 12, 189-198.
12.
Fowler, F.J.J.R., Cleary, P.D., Massagli, M.P., Weissman, J., & Epstein, A. ( 1995). The role of reluctance to give up life in the measurement of the values of health states. Medical Decision Making, 15, 195-200.
13.
Grimison, P.S., Simes, R.J., Hudson, H.M., & Stockler, M.R. (2009). Deriving a Patient-Based Utility Index from a Cancer-Specific Quality of Life Questionnaire. Value Health, 12, 800-807.
14.
Handler, R.M., Hynes, L.M., & Nease, R.F., Jr. (1997). Effect of locus of control and consideration of future consequences on time tradeoff utilities for current health. Quality of Life Research, 6, 54-60.
15.
Healthy People. (2010). A Systematic approach to health improvement. Retrieved September 21, 2009 , from http://www.healthypeople.gov/document/html/uih/uih_2.htm
16.
Lawton, M.P., Moss, M., Hoffman, C., Grant, R., Have, T.T., & Kleban, M.H. ( 1999). Health, valuation of life, and the wish to live. The Gerontologist, 39, 406-416.
17.
Lloyd, A., van Hanswijck de Jonge, P., Doyle, S., & Cornes, P. ( 2008). Health state utility scores for cancer-related anemia through societal and patient valuations. Value in Health, 11, 1178-1185.
18.
Martin, A.J., Glasziou, P.P., Simes, R.J., & Lumley, T. ( 2000). A comparison of standard gamble, time trade-off, and adjusted time trade-off scores. International Journal of Technology Assessment in Health Care, 16, 137-147.
19.
Meropol, N.J., Egleston, B.L., Buzaglo, J.S., Benson, A.B., Cegala, D.J., Diefenbach, M.A., et al. (2008). Cancer patient preferences for quality and length of life. Cancer, 113, 3459-3466.
20.
O’Leary, J.F., Fairclough, D.L., Jankowski, M.K., & Weeks, J.C. ( 1995). Comparison of time-tradeoff utilities and Rating Scale Values of cancer patients and their relatives: Evidence for a possible plateau relationship. Medical Decision Making, 15, 132-137.
21.
Radloff, L.S. ( 1977). The CES-D Scale: A Self-Report Depression Scale for research in the general population. Applied Psychological Measurement , 1, 385-401.
22.
Steffick, D.E. ( 2000). Documentation of affective functioning measures in the Health and Retirement Study: HRS Documentation Report DR-005. Retrieved May 3, 2010, from http://hrsonline.isr.umich.edu/sitedocs/userg/dr-005.pdf
23.
Stiggelbout, A.M., De Haes, J.C.J.M., Kiebert, G.M., Kievit, J., & Leer, J.-W.H. ( 1996). Tradeoffs between quality and quantity of life: Development of the QQ questionnaire for cancer patient attitudes. Medical Decision Making, 16, 184-192.
24.
Tsevat, J., Dawson, N.V., Wu, A.W., Lynn, J., Soukup, J.R., Cook, E.F., et al. (1998). Health values of hospitalized patients 80 years or older. Journal of the American Medical Association , 279, 371-375.
25.
Ubel, P.A., Jankovic, A., Smith, D., Langa, K.M., & Fagerlin, A. ( 2005). What is perfect health to an 85-year-old?: Evidence for scale recalibration in subjective health ratings. Medical Care, 43, 1054-1057.
26.
van Nooten, F.E., Koolman, X., & Brouwer, W.B. ( 2009). The influence of subjective life expectancy on health state valuations using a 10 year TTO. Health Economics, 18, 549-558.
27.
Voogt, E., van der Heide, A., Rietjens, J.A., van Leeuwen, A.F., Visser, A.P., van der Rijt, C.C., et al. (2005). Attitudes of patients with incurable cancer toward medical treatment in the last phase of life. Journal of Clinical Oncology, 23, 2012-2019.
